The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
From our global headquarters in Austria we run a dynamic operation providing innovative therapies and value-added formulations aimed at enhancing patient and healthcare professional’s lives through improved safety and convenience.
Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency substances, crystal suspensions in vials, pre-filled syringes, ampoules and implants.
We market our products in more than 70 countries around the world through 25 international affiliated companies and strategic partners.